ContraFect

ContraFect FCF/Debt

The Free Cash Flow to Debt Ratio of ContraFect (CFRXQ) as of Oct 19, 2026 is -141.50 %. In the previous year, Free Cash Flow to Debt Ratio was -236.52 % — a change of -40.17% (higher).

FCF/Debt

-141.50 %

YoY

-40.17%

Last updated:

Free Cash Flow to Debt Ratio of ContraFect is 2022 -141.50 % . Free Cash Flow to Debt Ratio of ContraFect was 2021 -236.52 % . It decreases by -40.17% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ContraFect Stock analysis

What does ContraFect do? ContraFect Corp, based in Yonkers, New York, is a clinical-stage biotechnology company focused on developing direct lytic agents (DLAs) such as lysins and amurin peptides to treat life-threatening antibiotic-resistant infections. The company, listed in 2014, employs 23 people and is advancing its lead candidate exebacase (CF-301) for MRSA bloodstream infections and chronic prosthetic joint infections, alongside CF-370 targeting gram-negative bacteria. ContraFect is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContraFect stock

Free Cash Flow to Debt Ratio of ContraFect is -141.50 % in 2022.

Free Cash Flow to Debt Ratio of ContraFect changed from -236.52 % to -141.50 %, representing a -40.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio ContraFect since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's ContraFect with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — ContraFect

All Key Metrics — ContraFect